Researchers at the Spanish National Cancer Research Center (CNIO) propose a new treatment for brain metastases that respond ...

Cancer immunotherapy has emerged as a groundbreaking approach in the field of medicine, significantly evolving over the past ...

BOSTON, Oct. 04, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class ...

A Cleveland Clinic-led research collaboration between Timothy Chan, MD, Ph.D., Chair of Cleveland Clinic's Global Center for ...

SEATTLE, Oct. 04, 2024 (GLOBE NEWSWIRE) -- (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of CAR-T cell therapies in ...

An oncologist tells PEOPLE about the innovative cancer treatment that extended the former president’s life as he celebrates ...

In a follow-up study, researchers compared cancer immunotherapy in mice, using either single or double immune responses. And ...

When cancer cells mutate, they produce small peptides called neoantigens.  Because neoantigens remain relatively unique to ...

Lyell Immunopharma Announces the Acceptance Abstracts for Presentation at 2024 Society for Immunotherapy of Cancer (SITC) ...

A phase 2/3 non-inferiority study compared de-escalation strategies to standard chemoradiation in patients with human ...

Thanks to early detection through widespread screening and dramatic breakthroughs in immunotherapy and other cancer ...

Poster presentation details: Title: Tumor-activated immune cell engagers designed to drive synthetic immunity against cancer demonstrated protease-dependent activation and robust anti-tumor activity ...